drugset / Trial / NCT01091649

Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

NCT01091649

Phase 1 Completed 40 enrolled Abbott
RandomizedCrossoverOpen-label

Summary

The objective of this study is to assess the relative bioavailability of two test tablet formulations of ABT-450 as compared to the ABT-450 hard gelatin capsule formulation as a reference.

Timeline

Start
2010-02
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator paritaprevir Small molecule
Comparator Ritonavir Other / unclassified

Indications

No indication recorded.